TRILC Turk Ilac Ve Serum Sanayi Anonim Sirketi

0.0141USD0.7100 TRY · BIST+1.43%Mkt Cap: 14.60M USDP/E: 7.89

Turk Ilac Ve Serum Sanayi Anonim Sirketi produces and sells human tablets, capsules, ampoules, vials, ointments-creams, intravenous serums, parenteral solutions, nutritional solutions, amino acids, and other chemicals in…

Key Statistics

Company
Market Cap14.60M USD
Enterprise Value37.39M USD
Revenue (TTM)92.75M USD
Gross Profit31.70M USD
Net Income (TTM)-12.35M USD
Revenue/Share0.09 USD
Last Price0.0141 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees520
CountryTR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)7.89
P/E (Forward)—
PEG—
EV/EBITDA2.12
EV/Revenue0.40
P/S0.16
P/B0.51
EPS (TTM)0.0018 USD
EPS (Forward)—
52W Range
0.01351% of range0.0872
52W High0.0872 USD
52W Low0.0135 USD
Profitability
Gross Margin35.23%
Oper. Margin16.77%
EBITDA Margin18.98%
Profit Margin-13.72%
ROE-38.38%
ROA-9.04%
ROIC21.98%
ROCE45.25%
Growth
Revenue Growth-56.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF12.17M USD
CapEx (TTM)5.08M USD
FCF Margin15.29%
FCF Yield97.13%
Net Debt22.79M USD
Net Debt/EBITDA1.29
Net Debt/FCF1.61
Balance Sheet
Debt/Equity2.08
Current Ratio0.80
Quick Ratio0.56
Book Value/Sh0.03 USD
Cash/Share0.0001 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split640.8949:100
Split DateApr 27, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.04B
Float489.84M
Insiders26.76%
Institutions0.07%
Technical
SMA 500.0166 (-15.1%)
SMA 2000.0350 (-59.8%)
Beta0.29
S&P 52W Chg12.00%
Avg Vol (30d)2.97M
Avg Vol (10d)3.15M
Technical Indicators
RSI (14)38.4
MACD-0.0353
MACD Signal-0.0370
MACD Hist.+0.0017
BB Upper0.0164 USD
BB Middle0.0148 USD
BB Lower0.0131 USD
BB Width21.94%
ATR (14)0.0006 USD
Vol Ratio (20d)0.78x

About Turk Ilac Ve Serum Sanayi Anonim Sirketi (IST: TRILC)

›

Turk Ilac Ve Serum Sanayi Anonim Sirketi (IST: TRILC) is listed on Borsa Istanbul, where its shares trade in TRY. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 520 employees.

The shares were at 0.7100 TRY on 19 November 2026, down 75.4% over 52 weeks. Its 52-week range is 0.6800 TRY to 4.400 TRY: the price is 83.9% below the high and 4.4% above the low.

At a market capitalisation of 736.27M TRY, it trades at 7.9 times trailing earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.7, a discount of 68% for TRILC.

Turk Ilac Ve Serum Sanayi Anonim Sirketi reports return on equity of -38.4%, an operating margin of 16.8% and revenue down 56.1% year over year.

Its debt exceeds its cash by 1.15B TRY, a debt-to-equity ratio of 2.08. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.